Blood Products: Difference between revisions
No edit summary |
No edit summary |
||
Line 44: | Line 44: | ||
Revision as of 16:10, 31 December 2024
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
What’s in Your Transfusion? A Bedside Guide to Blood Products and Their Preparation
Error traps in Pediatric Patient Blood Management in the Perioperative Period
Peri-operative red blood cell transfusion in neonates and infants
Pediatric preoperative blood ordering: when is a type and screen or crossmatch really needed?
How to manage coagulopathies in critically ill patients
Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient
Prehospital tranexamic acid for trauma victims
Pediatric Blood Transfusion Therapy and Patient Blood Management
Clinical and laboratory diagnosis of VWD
WHO: The urgent need to implement patient blood management: policy brief
What’s in Your Transfusion? A Bedside Guide to Blood Products and Their Preparation
Reducing blood draw anemia
Small-volume tubes to reduce anemia and transfusion (STRATUS): a pilot study
Interventions to prevent iatrogenic anemia: a Laboratory Medicine Best Practices systematic review
Connolly SJ, Crowther M, Eikelboom JW, et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med. 2019 Apr 4; 380(14): 1326-1335. PMID: 30730782
Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015 Dec 17; 373(25): 2413-24. PMID: 26559317